Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2715-2026

VITEK 2 AST-N447 TEST KIT Product reference 424620 Recall

VITEK 2 AST-N447 TEST KIT Product reference 424620

FDA recall Class II

Ongoing

FDA lists this Class II recall for VITEK 2 AST-N447 TEST KIT Product reference 424620. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2715-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 4, 2026
FDA report date
Jul 15, 2026
Quantity in commerce
45,900 cards
Distribution
See key details
FDA cause
Process change control

What is being recalled?

VITEK 2 AST-N447 TEST KIT Product reference 424620

Affected model & UDI checker

Search the exact identifiers published for Z-2715-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedVITEK 2 AST-N447 TEST KIT Product reference 424620Check source notice03573026634551
FDA code information

Lot 0853293604 UDI-DI 03573026634551 Product is not registered in the US. OUS only.

View the original FDA recall notice

Why was this product recalled?

Potential for false resistant carbapenem and/or cephalosporin results when analyzing samples with kits from affected lot that have pouch foil fractures.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did BIOMERIEUX, Inc. take?

Firm began notifying customers on June 4, 2026. Customers are instructed to dispose of pouches from the affected lot (Ref 424620, Lot 0853293604). Customer may choose to inspect each pouch in their inventory and only dispose of those with "P7" on the label, or they may choose to dispose of all cards from Lot 0853293604 in their inventory. Based on individual customer policy, customers may wish to perform retrospective review of resistant results. Customers should distribute the information to all appropriate personnel in their laboratory. If product was transferred or further distributed, customer should notify downstream users/accounts.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology